On this page

Nystatin

Prescription ANDA TE AT Official labelling
Informational index, not medical advice. Content is reproduced from public FDA and NLM data. Always confirm against the manufacturer's current prescribing information. Report adverse events to FDA MedWatch.

Overview

Brand name
Nystatin
Generic name
Nystatin
Dosage form
Cream
Route
Topical
Marketing category
ANDA · ANDA
Labeler
Bryant Ranch Prepack
Product type
Human Prescription Drug
DEA schedule
Not scheduled
Active ingredients
3
NDC product codes
30
Packages
44
Data completeness
83% of corroborating sources present

Active ingredients

Source: NDC Directory
Active ingredients and strengths as listed in the NDC Directory.
Ingredient Strength RxCUI Monograph
Nystatin 100000 1/g 261178 View
Nystatin 100000 U/g 261178 View
Nystatin 100000 [USP'U]/g 261178 View

Forms, strengths and routes

Source: NDC Directory
Dosage form
Cream
Route of administration
Topical
Presentations
74

Pharmacologic classes are listed in the class section below.

Pharmacologic class

Source: NDC Directory
Established pharmacologic classes (EPC), mechanisms of action (MoA), chemical structures (CS) and physiologic effects (PE).
Class Type Browse
Polyene Antifungal [EPC] EPC All 12 members
Polyenes [CS] CS All 13 members

Regulatory status

Source: Drugs@FDANDC Directory
Application number
062225
Application type
ANDA · Abbreviated New Drug Application
Approval date
December 11, 1979
Sponsor
PADAGIS US
Products on application
1
Submissions recorded
9
Products approved under application 062225.
Product Trade name Form Strength Ingredient Status TE Flags
062225-001 NYSTATIN CREAM NYSTATIN Prescription AT

Therapeutic equivalence

Source: Orange Book
TE code
AT
Reference Listed Drug
No
Reference Standard
No

What this rating means: Therapeutically equivalent — bioequivalence demonstrated (topical dermatological products)

Codes beginning with “A” indicate products the FDA considers therapeutically equivalent. Codes beginning with “B” indicate bioequivalence has not been established. See methodology.

Approval history

Source: Drugs@FDA
Most recent submissions on application 062225.
Type No. Action Status Date Review
Supplement 11 Labeling Approved December 3, 2009 —
Supplement 10 Labeling Approved April 17, 2009 —
Supplement 8 Manufacturing (CMC) Approved September 5, 2000 —
Supplement 7 Manufacturing (CMC) Approved June 15, 1995 —
Supplement 6 Manufacturing (CMC) Approved June 15, 1995 —
Supplement 4 Labeling Approved July 6, 1994 —
Supplement 5 Labeling Approved October 4, 1993 —
Supplement 3 Manufacturing (CMC) Approved March 18, 1988 —
Original application 1 Approved December 11, 1979 —

Prescribing information

Source: openFDA Drug Labeling

Reproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20260706). This is the manufacturer's labelling text, not a summary and not advice.

HUMAN PRESCRIPTION DRUG · 20260706 HUMAN PRESCRIPTION DRUG · 20250515 HUMAN PRESCRIPTION DRUG · 20240814 HUMAN PRESCRIPTION DRUG · 20191101

Indications and Usage

openFDA Drug Labeling

INDICATIONS AND USAGE Nystatin Cream USP is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species. Nystatin Cream USP is not indicated for systemic, oral, intravaginal or ophthalmic use.

Dosage and Administration

openFDA Drug Labeling

DOSAGE AND ADMINISTRATION Very moist lesions are best treated with nystatin topical dusting powder. Adults and Pediatric Patients (Neonates and Older): Apply liberally to affected areas twice daily or as indicated until healing is complete.

Contraindications

openFDA Drug Labeling

CONTRAINDICATIONS Nystatin Cream USP is contraindicated in patients with a history of hypersensitivity to any of its components.

Adverse Reactions

openFDA Drug Labeling

ADVERSE REACTIONS The frequency of adverse events reported in patients using nystatin cream is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application. (See PRECAUTIONS: General . ) To report SUSPECTED ADVERSE REACTIONS, contact Cosette Pharmaceuticals, Inc. at 1-800-922-1038 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .

Description

openFDA Drug Labeling

DESCRIPTION Nystatin is a polyene antifungal antibiotic obtained from Streptomyces nursei . Structural formula: C47H75NO17 Molecular Weight: 926.13 Nystatin cream is for dermatologic use. Nystatin cream for topical use, contains 100,000 USP nystatin units per gram in an aqueous, perfumed cream base containing aluminum hydroxide gel, ceteareth-15, glyceryl monostearate, polyethylene glycol 400 monostearate, propylene glycol, purified water, simethicone emulsion, sorbitol solution, titanium dioxide, white petrolatum, with methylparaben and propylparaben as preservatives and, if necessary, sodium hydroxide for pH adjustment. Chemical Structure

How Supplied / Storage and Handling

openFDA Drug Labeling

HOW SUPPLIED Nystatin Cream USP is a yellow to light green cream. It is supplied as: 15 gram Tube NDC 68788-4099-1 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Avoid freezing. Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540 Manufacturer: Macleods Pharmaceuticals Limited At Oxalis Labs Baddi, Himachal Pradesh, INDIA Rev. 08/2021 Relabeled By: Preferred Pharmaceuticals Inc.

Adverse event reports

Source: openFDA FAERS
27,387
FAERS reports mentioning this drug
as of 2026-09-25T03:42:24+00:00
A report count is not a risk measure. FAERS accepts voluntary and mandatory reports without establishing causation, and reporting is influenced by how widely a drug is used, how long it has been marketed, and media attention. FDA states that reports “do not prove that the drug caused the event”. Compare rates, not totals.

Attributed to this product's most-reported active ingredient: NYSTATIN. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.

Recalls

Source: FDA Enforcement
Drug recall enforcement reports associated with this product.
Classification Reported Firm Reason Status
Class II July 22, 2026 Padagis US LLC Subpotent Drug: Low out of specification assay results performed during long-term stability testing. Ongoing

Packaging and NDCs

Source: NDC Directory
Every National Drug Code package associated with this medication. The NDC is the identifier used for dispensing, billing and pharmacovigilance in the United States.
Package NDC Product NDC Labeler Description Marketing start
50090-2763-0 50090-2763 A-S Medication Solutions 1 TUBE in 1 CARTON (50090-2763-0) / 30 g in 1 TUBE January 9, 2017
50090-2854-0 50090-2854 A-S Medication Solutions 1 TUBE in 1 CARTON (50090-2854-0) / 15 g in 1 TUBE February 8, 2017
50090-3772-0 50090-3772 A-S Medication Solutions 1 TUBE in 1 CARTON (50090-3772-0) / 30 g in 1 TUBE November 5, 2018
50090-3799-0 50090-3799 A-S Medication Solutions 1 TUBE in 1 CARTON (50090-3799-0) / 15 g in 1 TUBE November 8, 2018
50090-7303-0 50090-7303 A-S Medication Solutions 15 g in 1 TUBE (50090-7303-0) October 14, 2024
59651-907-14 59651-907 Aurobindo Pharma Limited 1 TUBE in 1 CARTON (59651-907-14) / 15 g in 1 TUBE March 21, 2025
59651-907-30 59651-907 Aurobindo Pharma Limited 1 TUBE in 1 CARTON (59651-907-30) / 30 g in 1 TUBE March 21, 2025
63629-8694-1 63629-8694 Bryant Ranch Prepack 1 TUBE in 1 CARTON (63629-8694-1) / 15 g in 1 TUBE January 25, 2007
63629-8695-1 63629-8695 Bryant Ranch Prepack 1 TUBE in 1 CARTON (63629-8695-1) / 30 g in 1 TUBE September 21, 2006
71335-2830-1 71335-2830 Bryant Ranch Prepack 1 TUBE in 1 CARTON (71335-2830-1) / 30 g in 1 TUBE October 23, 2025
72162-1385-2 72162-1385 Bryant Ranch Prepack 1 TUBE in 1 CARTON (72162-1385-2) / 15 g in 1 TUBE April 2, 2025
72162-1385-3 72162-1385 Bryant Ranch Prepack 1 TUBE in 1 CARTON (72162-1385-3) / 30 g in 1 TUBE April 2, 2025
72162-2496-2 72162-2496 Bryant Ranch Prepack 1 TUBE in 1 CARTON (72162-2496-2) / 15 g in 1 TUBE May 15, 2025
72162-2496-3 72162-2496 Bryant Ranch Prepack 1 TUBE in 1 CARTON (72162-2496-3) / 30 g in 1 TUBE May 15, 2025
72162-2576-2 72162-2576 Bryant Ranch Prepack 15 g in 1 TUBE (72162-2576-2) November 17, 2025
72162-2576-3 72162-2576 Bryant Ranch Prepack 30 g in 1 TUBE (72162-2576-3) November 17, 2025
0713-0678-15 0713-0678 Cosette Pharmaceuticals, Inc. 1 TUBE in 1 CARTON (0713-0678-15) / 15 g in 1 TUBE April 1, 2015
0713-0678-31 0713-0678 Cosette Pharmaceuticals, Inc. 1 TUBE in 1 CARTON (0713-0678-31) / 30 g in 1 TUBE April 1, 2015
72189-278-15 72189-278 DIRECT RX 15 g in 1 BOX (72189-278-15) September 30, 2021
33342-469-15 33342-469 Macleods Pharmaceuticals Limited 1 TUBE in 1 CARTON (33342-469-15) / 15 g in 1 TUBE August 25, 2021
33342-469-30 33342-469 Macleods Pharmaceuticals Limited 1 TUBE in 1 CARTON (33342-469-30) / 30 g in 1 TUBE August 25, 2021
68071-3911-5 68071-3911 NuCare Pharmaceuticals, Inc. 1 TUBE in 1 CARTON (68071-3911-5) / 15 g in 1 TUBE November 6, 2025
66267-952-30 66267-952 NuCare Pharmaceuticals,Inc. 30 g in 1 BOX (66267-952-30) August 24, 2017
66267-953-15 66267-953 NuCare Pharmaceuticals,Inc. 15 g in 1 BOX (66267-953-15) April 18, 2019
68071-2556-5 68071-2556 NuCare Pharmaceuticals,Inc. 1 TUBE in 1 CARTON (68071-2556-5) / 15 g in 1 TUBE October 28, 2021
68071-4293-3 68071-4293 NuCare Pharmaceuticals,Inc. 30 g in 1 BOX (68071-4293-3) February 20, 2018
45802-059-11 45802-059 Padagis Israel Pharmaceuticals Ltd 1 TUBE in 1 CARTON (45802-059-11) / 30 g in 1 TUBE September 21, 2006
45802-059-35 45802-059 Padagis Israel Pharmaceuticals Ltd 1 TUBE in 1 CARTON (45802-059-35) / 15 g in 1 TUBE January 25, 2007
68788-4099-1 68788-4099 Preferred Pharmaceuticals Inc. 1 TUBE in 1 CARTON (68788-4099-1) / 15 g in 1 TUBE July 6, 2026
68788-8631-1 68788-8631 Preferred Pharmaceuticals Inc. 15 g in 1 TUBE (68788-8631-1) April 15, 2024
68788-8631-3 68788-8631 Preferred Pharmaceuticals Inc. 30 g in 1 TUBE (68788-8631-3) April 15, 2024
63187-703-15 63187-703 Proficient Rx LP 1 TUBE in 1 CARTON (63187-703-15) / 15 g in 1 TUBE June 1, 2016
63187-703-30 63187-703 Proficient Rx LP 1 TUBE in 1 CARTON (63187-703-30) / 30 g in 1 TUBE June 1, 2016
63187-847-15 63187-847 Proficient Rx LP 1 TUBE in 1 CARTON (63187-847-15) / 15 g in 1 TUBE May 1, 2017
63187-847-30 63187-847 Proficient Rx LP 1 TUBE in 1 CARTON (63187-847-30) / 30 g in 1 TUBE May 1, 2017
71205-723-30 71205-723 Proficient Rx LP 1 TUBE in 1 CARTON (71205-723-30) / 30 g in 1 TUBE November 17, 2022
82804-045-15 82804-045 Proficient Rx LP 15 g in 1 TUBE (82804-045-15) December 8, 2023
82804-045-30 82804-045 Proficient Rx LP 30 g in 1 TUBE (82804-045-30) December 8, 2023
67296-1519-1 67296-1519 RedPharm Drug, Inc 15 g in 1 TUBE (67296-1519-1) July 24, 2019
67296-1519-3 67296-1519 RedPharm Drug, Inc 30 g in 1 TUBE (67296-1519-3) July 24, 2019
51672-1289-1 51672-1289 Sun Pharmaceutical Industries, Inc. 1 TUBE in 1 CARTON (51672-1289-1) / 15 g in 1 TUBE January 28, 1993
51672-1289-2 51672-1289 Sun Pharmaceutical Industries, Inc. 1 TUBE in 1 CARTON (51672-1289-2) / 30 g in 1 TUBE January 28, 1993
13668-595-01 13668-595 Torrent Pharmaceuticals Limited 15 g in 1 TUBE (13668-595-01) July 24, 2019
13668-595-02 13668-595 Torrent Pharmaceuticals Limited 30 g in 1 TUBE (13668-595-02) July 24, 2019
50090-2763 50090-2763 A-S Medication Solutions — September 21, 2006
50090-2854 50090-2854 A-S Medication Solutions — September 21, 2006
50090-3772 50090-3772 A-S Medication Solutions — April 1, 2015
50090-3799 50090-3799 A-S Medication Solutions — April 1, 2015
50090-7303 50090-7303 A-S Medication Solutions — July 24, 2019
59651-907 59651-907 Aurobindo Pharma Limited — March 21, 2025
63629-8694 63629-8694 Bryant Ranch Prepack — September 21, 2006
63629-8695 63629-8695 Bryant Ranch Prepack — September 21, 2006
71335-2830 71335-2830 Bryant Ranch Prepack — September 21, 2006
72162-1385 72162-1385 Bryant Ranch Prepack — September 21, 2006
72162-2496 72162-2496 Bryant Ranch Prepack — August 25, 2021
72162-2576 72162-2576 Bryant Ranch Prepack — July 24, 2019
0713-0678 0713-0678 Cosette Pharmaceuticals, Inc. — April 1, 2015
72189-278 72189-278 DIRECT RX — September 30, 2021
33342-469 33342-469 Macleods Pharmaceuticals Limited — August 25, 2021
68071-3911 68071-3911 NuCare Pharmaceuticals, Inc. — April 1, 2015
66267-952 66267-952 NuCare Pharmaceuticals,Inc. — January 28, 1993
66267-953 66267-953 NuCare Pharmaceuticals,Inc. — September 21, 2006
68071-2556 68071-2556 NuCare Pharmaceuticals,Inc. — January 28, 1993
68071-4293 68071-4293 NuCare Pharmaceuticals,Inc. — September 21, 2006
45802-059 45802-059 Padagis Israel Pharmaceuticals Ltd — September 21, 2006
68788-4099 68788-4099 Preferred Pharmaceuticals Inc. — July 6, 2026
68788-8631 68788-8631 Preferred Pharmaceuticals Inc. — April 15, 2024
63187-703 63187-703 Proficient Rx LP — January 28, 1993
63187-847 63187-847 Proficient Rx LP — September 21, 2006
71205-723 71205-723 Proficient Rx LP — April 1, 2015
82804-045 82804-045 Proficient Rx LP — July 24, 2019
67296-1519 67296-1519 RedPharm Drug, Inc — July 24, 2019
51672-1289 51672-1289 Sun Pharmaceutical Industries, Inc. — January 28, 1993
13668-595 13668-595 Torrent Pharmaceuticals Limited — July 24, 2019

Sources for this page

Every dataset that contributed a fact to this page.
Dataset Agency Used for
NDC Directory FDA Identity, ingredients, strengths, forms, routes, labelers, packages
Drugs@FDA FDA Application, sponsor, submissions, review documents, marketing status
Orange Book FDA Therapeutic equivalence codes, reference drug flags, patents, exclusivity
Drug Labeling FDA / NLM Prescribing information reproduced above
FAERS FDA Adverse event report counts
Enforcement FDA Recall records

Generated September 25, 2026 · 13 sections on this page.